EP2313077A1 - Stylingmittel mit hohem haltegrad und pflegegefühl - Google Patents
Stylingmittel mit hohem haltegrad und pflegegefühlInfo
- Publication number
- EP2313077A1 EP2313077A1 EP09780005A EP09780005A EP2313077A1 EP 2313077 A1 EP2313077 A1 EP 2313077A1 EP 09780005 A EP09780005 A EP 09780005A EP 09780005 A EP09780005 A EP 09780005A EP 2313077 A1 EP2313077 A1 EP 2313077A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- copolymers
- copolymer
- formula
- kda
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 230000001143 conditioned effect Effects 0.000 title abstract 2
- 229920001577 copolymer Polymers 0.000 claims abstract description 157
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 114
- 210000004209 hair Anatomy 0.000 claims abstract description 53
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 36
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims abstract description 32
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims abstract description 28
- 125000005396 acrylic acid ester group Chemical group 0.000 claims abstract description 13
- 239000000835 fiber Substances 0.000 claims abstract description 12
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 9
- 229920000058 polyacrylate Polymers 0.000 claims abstract description 9
- 229920006395 saturated elastomer Polymers 0.000 claims abstract description 9
- IAUGBVWVWDTCJV-UHFFFAOYSA-N 1-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound CCC(S(O)(=O)=O)NC(=O)C=C IAUGBVWVWDTCJV-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229920003145 methacrylic acid copolymer Polymers 0.000 claims abstract description 7
- 125000005397 methacrylic acid ester group Chemical group 0.000 claims abstract description 6
- 239000004584 polyacrylic acid Substances 0.000 claims abstract description 6
- -1 N-substituted acrylamides Chemical class 0.000 claims description 90
- 229920000642 polymer Polymers 0.000 claims description 84
- 239000000203 mixture Substances 0.000 claims description 57
- 239000000178 monomer Substances 0.000 claims description 46
- 125000000217 alkyl group Chemical group 0.000 claims description 32
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 18
- 239000000443 aerosol Substances 0.000 claims description 16
- 239000006260 foam Substances 0.000 claims description 16
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 13
- 239000002537 cosmetic Substances 0.000 claims description 13
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 claims description 13
- 239000008266 hair spray Substances 0.000 claims description 10
- UZNHKBFIBYXPDV-UHFFFAOYSA-N trimethyl-[3-(2-methylprop-2-enoylamino)propyl]azanium;chloride Chemical compound [Cl-].CC(=C)C(=O)NCCC[N+](C)(C)C UZNHKBFIBYXPDV-UHFFFAOYSA-N 0.000 claims description 8
- 150000001450 anions Chemical class 0.000 claims description 6
- 229930195733 hydrocarbon Natural products 0.000 claims description 6
- 239000004215 Carbon black (E152) Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 claims description 4
- FLCAEMBIQVZWIF-UHFFFAOYSA-N 6-(dimethylamino)-2-methylhex-2-enamide Chemical compound CN(C)CCCC=C(C)C(N)=O FLCAEMBIQVZWIF-UHFFFAOYSA-N 0.000 claims description 4
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract description 18
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract description 5
- 102000011782 Keratins Human genes 0.000 abstract description 3
- 108010076876 Keratins Proteins 0.000 abstract description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 abstract description 3
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract description 3
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 description 48
- 239000000047 product Substances 0.000 description 43
- 229920001296 polysiloxane Polymers 0.000 description 31
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 29
- 239000000194 fatty acid Substances 0.000 description 29
- 235000014113 dietary fatty acids Nutrition 0.000 description 28
- 229930195729 fatty acid Natural products 0.000 description 28
- 239000000126 substance Substances 0.000 description 19
- 150000004665 fatty acids Chemical class 0.000 description 18
- 150000001720 carbohydrates Chemical class 0.000 description 15
- 239000004094 surface-active agent Substances 0.000 description 15
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 14
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 14
- 239000012530 fluid Substances 0.000 description 13
- 239000003995 emulsifying agent Substances 0.000 description 12
- 229920001400 block copolymer Polymers 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 11
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 11
- 150000003254 radicals Chemical class 0.000 description 11
- 229920006317 cationic polymer Polymers 0.000 description 10
- 239000000839 emulsion Substances 0.000 description 10
- 239000000499 gel Substances 0.000 description 10
- 125000002091 cationic group Chemical group 0.000 description 9
- 239000004205 dimethyl polysiloxane Substances 0.000 description 9
- 150000002148 esters Chemical class 0.000 description 9
- 239000003531 protein hydrolysate Substances 0.000 description 9
- 150000003839 salts Chemical class 0.000 description 9
- 239000004698 Polyethylene Substances 0.000 description 8
- 108010009736 Protein Hydrolysates Proteins 0.000 description 8
- 229940008099 dimethicone Drugs 0.000 description 8
- 235000000346 sugar Nutrition 0.000 description 8
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 8
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 239000003093 cationic surfactant Substances 0.000 description 7
- 150000002191 fatty alcohols Chemical class 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 239000003380 propellant Substances 0.000 description 7
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 6
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 125000004122 cyclic group Chemical group 0.000 description 6
- 229910052739 hydrogen Inorganic materials 0.000 description 6
- 238000010348 incorporation Methods 0.000 description 6
- 235000019156 vitamin B Nutrition 0.000 description 6
- 239000011720 vitamin B Substances 0.000 description 6
- 239000004604 Blowing Agent Substances 0.000 description 5
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 5
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 5
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 5
- 229930003270 Vitamin B Natural products 0.000 description 5
- 150000007513 acids Chemical class 0.000 description 5
- 150000001412 amines Chemical class 0.000 description 5
- 125000000129 anionic group Chemical group 0.000 description 5
- 239000013065 commercial product Substances 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 5
- 239000002736 nonionic surfactant Substances 0.000 description 5
- 125000001453 quaternary ammonium group Chemical group 0.000 description 5
- 229920002545 silicone oil Polymers 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- QLAJNZSPVITUCQ-UHFFFAOYSA-N 1,3,2-dioxathietane 2,2-dioxide Chemical compound O=S1(=O)OCO1 QLAJNZSPVITUCQ-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 4
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 4
- 125000002252 acyl group Chemical group 0.000 description 4
- 150000001335 aliphatic alkanes Chemical class 0.000 description 4
- 239000003945 anionic surfactant Substances 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 235000017471 coenzyme Q10 Nutrition 0.000 description 4
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- WQXNXVUDBPYKBA-YFKPBYRVSA-N ectoine Chemical compound CC1=[NH+][C@H](C([O-])=O)CCN1 WQXNXVUDBPYKBA-YFKPBYRVSA-N 0.000 description 4
- 239000003623 enhancer Substances 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- 229920001519 homopolymer Polymers 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 4
- QWTDNUCVQCZILF-UHFFFAOYSA-N isopentane Chemical compound CCC(C)C QWTDNUCVQCZILF-UHFFFAOYSA-N 0.000 description 4
- 235000019161 pantothenic acid Nutrition 0.000 description 4
- 239000011713 pantothenic acid Substances 0.000 description 4
- 229920000223 polyglycerol Polymers 0.000 description 4
- 229920000151 polyglycol Polymers 0.000 description 4
- 239000010695 polyglycol Substances 0.000 description 4
- 229920005862 polyol Polymers 0.000 description 4
- 150000003077 polyols Chemical class 0.000 description 4
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 4
- 229960003080 taurine Drugs 0.000 description 4
- 230000008719 thickening Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- 239000002888 zwitterionic surfactant Substances 0.000 description 4
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 229920000289 Polyquaternium Polymers 0.000 description 3
- 229930182558 Sterol Natural products 0.000 description 3
- 229940048053 acrylate Drugs 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 125000003342 alkenyl group Chemical group 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical class [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 3
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 150000001805 chlorine compounds Chemical class 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 150000005690 diesters Chemical class 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 150000002772 monosaccharides Chemical class 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 229940101267 panthenol Drugs 0.000 description 3
- 229940055726 pantothenic acid Drugs 0.000 description 3
- 239000011619 pantothenol Substances 0.000 description 3
- 235000020957 pantothenol Nutrition 0.000 description 3
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 239000002453 shampoo Substances 0.000 description 3
- 238000007493 shaping process Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 150000003432 sterols Chemical class 0.000 description 3
- 235000003702 sterols Nutrition 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 3
- 229940035936 ubiquinone Drugs 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
- HQLVRJJDJGNYQW-UHFFFAOYSA-N 1-prop-1-enylimidazole Chemical compound CC=CN1C=CN=C1 HQLVRJJDJGNYQW-UHFFFAOYSA-N 0.000 description 2
- RZALONVQKUWRRY-FYZOBXCZSA-N 2,3-dihydroxybutanedioic acid;(3r)-3-hydroxy-4-(trimethylazaniumyl)butanoate Chemical compound OC(=O)C(O)C(O)C(O)=O.C[N+](C)(C)C[C@H](O)CC([O-])=O RZALONVQKUWRRY-FYZOBXCZSA-N 0.000 description 2
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 2
- DEVLFMFUNRCKGE-FYZOBXCZSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;(3r)-3-hydroxy-4-(trimethylazaniumyl)butanoate Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O.OC(=O)CC(O)(C(O)=O)CC(O)=O DEVLFMFUNRCKGE-FYZOBXCZSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-M Aminoacetate Chemical compound NCC([O-])=O DHMQDGOQFOQNFH-UHFFFAOYSA-M 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 101150065749 Churc1 gene Proteins 0.000 description 2
- 244000303965 Cyamopsis psoralioides Species 0.000 description 2
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- RDHQFKQIGNGIED-MRVPVSSYSA-N O-acetyl-L-carnitine Chemical compound CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C RDHQFKQIGNGIED-MRVPVSSYSA-N 0.000 description 2
- FUJLYHJROOYKRA-QGZVFWFLSA-N O-lauroyl-L-carnitine Chemical compound CCCCCCCCCCCC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C FUJLYHJROOYKRA-QGZVFWFLSA-N 0.000 description 2
- 102100038239 Protein Churchill Human genes 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 2
- HNSUOMBUJRUZHJ-REVJHSINSA-N [(2r)-3-carboxy-2-hydroxypropyl]-trimethylazanium;(z)-4-hydroxy-4-oxobut-2-enoate Chemical compound OC(=O)\C=C/C(O)=O.C[N+](C)(C)C[C@H](O)CC([O-])=O HNSUOMBUJRUZHJ-REVJHSINSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 150000007942 carboxylates Chemical group 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical group OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 2
- AFABGHUZZDYHJO-UHFFFAOYSA-N dimethyl butane Natural products CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 2
- YIOJGTBNHQAVBO-UHFFFAOYSA-N dimethyl-bis(prop-2-enyl)azanium Chemical class C=CC[N+](C)(C)CC=C YIOJGTBNHQAVBO-UHFFFAOYSA-N 0.000 description 2
- 150000002016 disaccharides Chemical class 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000004815 dispersion polymer Substances 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- TVFJAZCVMOXQRK-UHFFFAOYSA-N ethenyl 7,7-dimethyloctanoate Chemical compound CC(C)(C)CCCCCC(=O)OC=C TVFJAZCVMOXQRK-UHFFFAOYSA-N 0.000 description 2
- 125000001033 ether group Chemical group 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 239000002563 ionic surfactant Substances 0.000 description 2
- 239000001282 iso-butane Substances 0.000 description 2
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 2
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical class C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 230000005501 phase interface Effects 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 229940068065 phytosterols Drugs 0.000 description 2
- 229940051841 polyoxyethylene ether Drugs 0.000 description 2
- 229920000056 polyoxyethylene ether Polymers 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 229940115476 ppg-1 trideceth-6 Drugs 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 239000001294 propane Substances 0.000 description 2
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 229920005573 silicon-containing polymer Polymers 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- FWFUWXVFYKCSQA-UHFFFAOYSA-M sodium;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C FWFUWXVFYKCSQA-UHFFFAOYSA-M 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 2
- 150000003871 sulfonates Chemical class 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- BQPPJGMMIYJVBR-UHFFFAOYSA-N (10S)-3c-Acetoxy-4.4.10r.13c.14t-pentamethyl-17c-((R)-1.5-dimethyl-hexen-(4)-yl)-(5tH)-Delta8-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C BQPPJGMMIYJVBR-UHFFFAOYSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- JHPBZFOKBAGZBL-UHFFFAOYSA-N (3-hydroxy-2,2,4-trimethylpentyl) 2-methylprop-2-enoate Chemical compound CC(C)C(O)C(C)(C)COC(=O)C(C)=C JHPBZFOKBAGZBL-UHFFFAOYSA-N 0.000 description 1
- CHGIKSSZNBCNDW-UHFFFAOYSA-N (3beta,5alpha)-4,4-Dimethylcholesta-8,24-dien-3-ol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21 CHGIKSSZNBCNDW-UHFFFAOYSA-N 0.000 description 1
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 1
- BYEUGKXDVZGBLP-UHFFFAOYSA-M 1-ethenylazepan-2-one;1-ethenyl-3-methylimidazol-3-ium;1-ethenylpyrrolidin-2-one;methyl sulfate Chemical compound COS([O-])(=O)=O.C[N+]=1C=CN(C=C)C=1.C=CN1CCCC1=O.C=CN1CCCCCC1=O BYEUGKXDVZGBLP-UHFFFAOYSA-M 0.000 description 1
- PBGPBHYPCGDFEZ-UHFFFAOYSA-N 1-ethenylpiperidin-2-one Chemical group C=CN1CCCCC1=O PBGPBHYPCGDFEZ-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- OVYMWJFNQQOJBU-UHFFFAOYSA-N 1-octanoyloxypropan-2-yl octanoate Chemical compound CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC OVYMWJFNQQOJBU-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- ULQISTXYYBZJSJ-UHFFFAOYSA-M 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC([O-])=O ULQISTXYYBZJSJ-UHFFFAOYSA-M 0.000 description 1
- 229940114069 12-hydroxystearate Drugs 0.000 description 1
- XYTLYKGXLMKYMV-UHFFFAOYSA-N 14alpha-methylzymosterol Natural products CC12CCC(O)CC1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C XYTLYKGXLMKYMV-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- NFIHXTUNNGIYRF-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCC NFIHXTUNNGIYRF-UHFFFAOYSA-N 0.000 description 1
- MLMGJTAJUDSUKA-UHFFFAOYSA-N 2-ethenyl-1h-imidazole Chemical group C=CC1=NC=CN1 MLMGJTAJUDSUKA-UHFFFAOYSA-N 0.000 description 1
- PUSPAPGHKSLKKH-UHFFFAOYSA-N 2-methyl-1,2-thiazolidin-3-one Chemical class CN1SCCC1=O PUSPAPGHKSLKKH-UHFFFAOYSA-N 0.000 description 1
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- BXAAQNFGSQKPDZ-UHFFFAOYSA-N 3-[1,2,2-tris(prop-2-enoxy)ethoxy]prop-1-ene Chemical compound C=CCOC(OCC=C)C(OCC=C)OCC=C BXAAQNFGSQKPDZ-UHFFFAOYSA-N 0.000 description 1
- MXRGSJAOLKBZLU-UHFFFAOYSA-N 3-ethenylazepan-2-one Chemical group C=CC1CCCCNC1=O MXRGSJAOLKBZLU-UHFFFAOYSA-N 0.000 description 1
- ATVJXMYDOSMEPO-UHFFFAOYSA-N 3-prop-2-enoxyprop-1-ene Chemical compound C=CCOCC=C ATVJXMYDOSMEPO-UHFFFAOYSA-N 0.000 description 1
- FPTJELQXIUUCEY-UHFFFAOYSA-N 3beta-Hydroxy-lanostan Natural products C1CC2C(C)(C)C(O)CCC2(C)C2C1C1(C)CCC(C(C)CCCC(C)C)C1(C)CC2 FPTJELQXIUUCEY-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241000233788 Arecaceae Species 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- HYOOVBLNWIDOFM-UHFFFAOYSA-O CCCCCCCCCCCCC=C(C)C(=O)N[N+](C)(C)CCC Chemical class CCCCCCCCCCCCC=C(C)C(=O)N[N+](C)(C)CCC HYOOVBLNWIDOFM-UHFFFAOYSA-O 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- SRBFZHDQGSBBOR-SOOFDHNKSA-N D-ribopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@@H]1O SRBFZHDQGSBBOR-SOOFDHNKSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 239000004266 EU approved firming agent Substances 0.000 description 1
- WQXNXVUDBPYKBA-UHFFFAOYSA-N Ectoine Natural products CC1=NCCC(C(O)=O)N1 WQXNXVUDBPYKBA-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- KIWBPDUYBMNFTB-UHFFFAOYSA-N Ethyl hydrogen sulfate Chemical compound CCOS(O)(=O)=O KIWBPDUYBMNFTB-UHFFFAOYSA-N 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- BKLIAINBCQPSOV-UHFFFAOYSA-N Gluanol Natural products CC(C)CC=CC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(O)C(C)(C)C4CC3 BKLIAINBCQPSOV-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
- SHZGCJCMOBCMKK-PQMKYFCFSA-N L-Fucose Natural products C[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O SHZGCJCMOBCMKK-PQMKYFCFSA-N 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- LOPKHWOTGJIQLC-UHFFFAOYSA-N Lanosterol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 LOPKHWOTGJIQLC-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000004165 Methyl ester of fatty acids Substances 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- CAHGCLMLTWQZNJ-UHFFFAOYSA-N Nerifoliol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C CAHGCLMLTWQZNJ-UHFFFAOYSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- AYRXSINWFIIFAE-UHFFFAOYSA-N O6-alpha-D-Galactopyranosyl-D-galactose Natural products OCC1OC(OCC(O)C(O)C(O)C(O)C=O)C(O)C(O)C1O AYRXSINWFIIFAE-UHFFFAOYSA-N 0.000 description 1
- 239000004435 Oxo alcohol Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000282372 Panthera onca Species 0.000 description 1
- 229920000688 Poly[(2-ethyldimethylammonioethyl methacrylate ethyl sulfate)-co-(1-vinylpyrrolidone)] Polymers 0.000 description 1
- 229920000691 Poly[bis(2-chloroethyl) ether-alt-1,3-bis[3-(dimethylamino)propyl]urea] Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 108010013296 Sericins Proteins 0.000 description 1
- 244000258044 Solanum gilo Species 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical class OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229920004482 WACKER® Polymers 0.000 description 1
- HGHAGJPXZLUPQV-FYZOBXCZSA-N [(2r)-3-carboxy-2-hydroxypropyl]-trimethylazanium;hydroxide Chemical compound [OH-].C[N+](C)(C)C[C@H](O)CC(O)=O HGHAGJPXZLUPQV-FYZOBXCZSA-N 0.000 description 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 description 1
- 229920006322 acrylamide copolymer Polymers 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 125000005041 acyloxyalkyl group Chemical group 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 230000009435 amidation Effects 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 210000000077 angora Anatomy 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 150000001449 anionic compounds Chemical class 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 150000005840 aryl radicals Chemical class 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 229940110830 beheneth-25 methacrylate Drugs 0.000 description 1
- JBIROUFYLSSYDX-UHFFFAOYSA-M benzododecinium chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 JBIROUFYLSSYDX-UHFFFAOYSA-M 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- VHIZYFAEPDWBFM-UHFFFAOYSA-M bis(2-hexadecanoyloxyethyl)-dimethylazanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC(=O)OCC[N+](C)(C)CCOC(=O)CCCCCCCCCCCCCCC VHIZYFAEPDWBFM-UHFFFAOYSA-M 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- RHDGNLCLDBVESU-UHFFFAOYSA-N but-3-en-4-olide Chemical class O=C1CC=CO1 RHDGNLCLDBVESU-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 239000004221 calcium diglutamate Substances 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229940073669 ceteareth 20 Drugs 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004581 coalescence Methods 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- 229940096386 coconut alcohol Drugs 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000003766 combability Effects 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- QBSJHOGDIUQWTH-UHFFFAOYSA-N dihydrolanosterol Natural products CC(C)CCCC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 QBSJHOGDIUQWTH-UHFFFAOYSA-N 0.000 description 1
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 1
- ROSDSFDQCJNGOL-UHFFFAOYSA-O dimethylaminium Chemical compound C[NH2+]C ROSDSFDQCJNGOL-UHFFFAOYSA-O 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- PGQAXGHQYGXVDC-UHFFFAOYSA-N dodecyl(dimethyl)azanium;chloride Chemical compound Cl.CCCCCCCCCCCCN(C)C PGQAXGHQYGXVDC-UHFFFAOYSA-N 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- DLRVVLDZNNYCBX-CQUJWQHSSA-N gentiobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-CQUJWQHSSA-N 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- PMMXXYHTOMKOAZ-UHFFFAOYSA-N hexadecyl 7-methyloctanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCC(C)C PMMXXYHTOMKOAZ-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 150000004693 imidazolium salts Chemical class 0.000 description 1
- 229910001412 inorganic anion Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940058690 lanosterol Drugs 0.000 description 1
- CAHGCLMLTWQZNJ-RGEKOYMOSA-N lanosterol Chemical compound C([C@]12C)C[C@@H](O)C(C)(C)[C@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@@]21C CAHGCLMLTWQZNJ-RGEKOYMOSA-N 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 125000005528 methosulfate group Chemical group 0.000 description 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 description 1
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 1
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 229940049292 n-(3-(dimethylamino)propyl)octadecanamide Drugs 0.000 description 1
- WWVIUVHFPSALDO-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCCN(C)C WWVIUVHFPSALDO-UHFFFAOYSA-N 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012875 nonionic emulsifier Substances 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 238000006384 oligomerization reaction Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000002891 organic anions Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000008385 outer phase Substances 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- SERHXTVXHNVDKA-UHFFFAOYSA-N pantolactone Chemical compound CC1(C)COC(=O)C1O SERHXTVXHNVDKA-UHFFFAOYSA-N 0.000 description 1
- SIEVQTNTRMBCHO-UHFFFAOYSA-N pantolactone Natural products CC1(C)OC(=O)CC1O SIEVQTNTRMBCHO-UHFFFAOYSA-N 0.000 description 1
- 229940115458 pantolactone Drugs 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229940057874 phenyl trimethicone Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 150000008105 phosphatidylcholines Chemical class 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229920002553 poly(2-methacrylolyloxyethyltrimethylammonium chloride) polymer Polymers 0.000 description 1
- 229920001521 polyalkylene glycol ether Polymers 0.000 description 1
- 229920006294 polydialkylsiloxane Polymers 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940068965 polysorbates Drugs 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- FJWSMXKFXFFEPV-UHFFFAOYSA-N prop-2-enamide;hydrochloride Chemical compound Cl.NC(=O)C=C FJWSMXKFXFFEPV-UHFFFAOYSA-N 0.000 description 1
- BOQSSGDQNWEFSX-UHFFFAOYSA-N propan-2-yl 2-methylprop-2-enoate Chemical compound CC(C)OC(=O)C(C)=C BOQSSGDQNWEFSX-UHFFFAOYSA-N 0.000 description 1
- LYBIZMNPXTXVMV-UHFFFAOYSA-N propan-2-yl prop-2-enoate Chemical compound CC(C)OC(=O)C=C LYBIZMNPXTXVMV-UHFFFAOYSA-N 0.000 description 1
- NHARPDSAXCBDDR-UHFFFAOYSA-N propyl 2-methylprop-2-enoate Chemical compound CCCOC(=O)C(C)=C NHARPDSAXCBDDR-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- PNXMTCDJUBJHQJ-UHFFFAOYSA-N propyl prop-2-enoate Chemical compound CCCOC(=O)C=C PNXMTCDJUBJHQJ-UHFFFAOYSA-N 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 229940079053 quaternium-27 Drugs 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229940047670 sodium acrylate Drugs 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- DHCDFWKWKRSZHF-UHFFFAOYSA-L thiosulfate(2-) Chemical group [O-]S([S-])(=O)=O DHCDFWKWKRSZHF-UHFFFAOYSA-L 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-M toluene-4-sulfonate Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-M 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- FAGMGMRSURYROS-UHFFFAOYSA-M trihexadecyl(methyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(CCCCCCCCCCCCCCCC)CCCCCCCCCCCCCCCC FAGMGMRSURYROS-UHFFFAOYSA-M 0.000 description 1
- RRHXZLALVWBDKH-UHFFFAOYSA-M trimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azanium;chloride Chemical compound [Cl-].CC(=C)C(=O)OCC[N+](C)(C)C RRHXZLALVWBDKH-UHFFFAOYSA-M 0.000 description 1
- OEIXGLMQZVLOQX-UHFFFAOYSA-N trimethyl-[3-(prop-2-enoylamino)propyl]azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CCCNC(=O)C=C OEIXGLMQZVLOQX-UHFFFAOYSA-N 0.000 description 1
- 229940040064 ubiquinol Drugs 0.000 description 1
- QNTNKSLOFHEFPK-UPTCCGCDSA-N ubiquinol-10 Chemical compound COC1=C(O)C(C)=C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=C1OC QNTNKSLOFHEFPK-UPTCCGCDSA-N 0.000 description 1
- 229940119423 ultracare Drugs 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019159 vitamin B9 Nutrition 0.000 description 1
- 239000011727 vitamin B9 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 239000003021 water soluble solvent Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 229910052725 zinc Chemical class 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
- A61K8/8176—Homopolymers of N-vinyl-pyrrolidones. Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/594—Mixtures of polymers
Definitions
- the present invention relates to means for the temporary deformation of keratinous fibers, comprising a combination of polymers with other specific ingredients, the use of these means for the temporary deformation of keratinous fibers and a corresponding method.
- keratinic fibers in principle, all animal hair, e.g. Wool, horsehair, angora hair, furs, feathers and products or textiles made from them.
- animal hair e.g. Wool, horsehair, angora hair, furs, feathers and products or textiles made from them.
- the keratinic fibers are human hairs.
- Corresponding temporary shaping agents usually contain synthetic polymers as the shaping component.
- Preparations containing a dissolved or dispersed polymer can be applied to the hair by means of propellant gases or by a pumping mechanism.
- hair gels and hair waxes are generally not applied directly to the hair, but distributed by means of a comb or hands in the hair.
- the most important property of a composition for the temporary deformation of keratinic fibers is to give the treated fibers in the produced form the strongest possible hold. If the keratin fibers are human hair, it is also referred to as a strong hairstyle or the high degree of retention of the styling agent.
- the hairstyle hold is essentially determined by the type and amount of the synthetic polymer used, but also an influence of the other constituents of the styling agent may be given. In addition to a high degree of hold, styling agents must meet a whole range of other requirements.
- properties on the hair may be broadly subdivided into properties on the hair, properties of the particular formulation, eg properties of the foam, of the gel or of the sprayed aerosol, and of properties which affect the handling of the styling agent, whereby the properties on the hair are of particular importance. Particularly noteworthy are moisture resistance, low tackiness and a balanced conditioning effect. Furthermore, a styling agent should be universally applicable as possible for all hair types.
- a high degree of retention is undesirably accompanied by a high brittleness of the hairstyle.
- the hair treated with the appropriate styling agent is rigid, brittle and unnaturally firm. As a result, they feel rough and unkempt.
- the polymer film which leave the means when applied to the hair in the cases mentioned inflexible so that it breaks under stress. This leads to the formation of so-called Filmpiaken, ie residues that detach during the movement of the hair and give the impression that the user of the corresponding styling agent would dandruff.
- Object of the present invention was therefore to provide a means for temporary deformation of keratinous fibers available, which is characterized by a very high degree of hold without the need for flexibility and a neat hair feel and pleasant product feel.
- a first subject of the present invention is therefore a cosmetic composition
- a cosmetic composition comprising, in a cosmetically acceptable carrier a) at least one copolymer A which contains at least one structural unit according to formula (I)
- R 1 is -H or -CH 3 and R 2 is -H or -CH 3 or -CH 2 CH 3 or -CH 2 CH 2 CH 3 or -CH (CH 3 ) 2 , and at least one further structural unit of the formula (II) which differs from structural unit (I)
- R 1 and R 2 independently of one another, are -CH 3 or -CH 2 CH 3 or -CH 2 CH 2 CH 3 or -CH (CH 3 ) 2 and R 3 is a saturated or unsaturated, straight-chain or branched hydrocarbon radical
- b at least one acrylate polymer B selected from b1) polyacrylic acid and / or b2) copolymers of methacrylic acid with acrylamidopropanesulfonic acid and / or b3) copolymers of acrylic acid with methacrylic acid and acrylic esters and / or b4) copolymers of acrylic acid with methacrylic acid with acrylic acid esters and
- Methacrylic acid esters and / or b5) copolymers of acrylic acid esters with methacrylic acid are examples of copolymers of acrylic acid esters with methacrylic acid.
- compositions according to the invention contain as the first compulsory component a polymer which is made up of at least two different monomers of the formulas (I) and (II). In addition, other monomers may be copolymerized.
- the first monomer contained in the copolymer A can be represented by the formula (I)
- R 1 is -H or -CH 3 and R 2 is -H or -CH 3 or -CH 2 CH 3 or -CH 2 CH 2 CH 3 or -CH (CH 3 ) 2 .
- Very particularly preferred monomers of the formula (I) are acrylic acid, methacrylic acid, methyl acrylate, methyl methacrylate, ethyl acrylate, ethyl methacrylate, propyl acrylate, propyl methacrylate, isopropyl acrylate and isopropyl methacrylate.
- Particularly preferred agents according to the invention comprise acrylic acid or acrylic ester as monomer unit in the copolymer A. Such agents are characterized in that the copolymer A contains structural units of the formula (Ia)
- R is -H or -CH 3 or -CH 2 CH 3 or -CH 2 CH 2 CH 3 or -CH (CH 3 ) 2 .
- the other monomer contained in the copolymer A can be represented by the formula (II)
- R1 and R2 of one another represent -CH 3 or -CH 2 CH 3 or - are CH 2 CH 2 CH 3 or -CH (CH 3) 2, and R3 represents a saturated or unsaturated, straight or branched chain hydrocarbon radical.
- R 3 is in each case a saturated or unsaturated, straight-chain or branched hydrocarbon radical.
- agents according to the invention which contain copolymer (e) A with molecular weights of from 10 to 750 kDa, preferably from 25 to 500 kDa, more preferably from 30 to 400 kDa and in particular from 4 to 250 kDa.
- agents according to the invention which contain, based on the weight of the ready-to-use agent, 0.1 to 10% by weight, preferably 0.5 to 7.5% by weight and in particular 1 to 5 wt .-% of copolymer (s) A included.
- the monomers of the formulas (I) and (II) are contained within certain limits in the copolymer A.
- preferred agents according to the invention are characterized in that they contain copolymer (e) A which contains 10 to 95 mol% (preferably 15 to 85 mol% and in particular 20 to 80 mol%) of monomers of the formula (I) and 5 to 90 mol% (preferably 7.5 to 80 mol% and especially 10 to 60 mol%) of monomers of the formula (II).
- compositions of the invention contain at least one further polymer B from the group of acrylate polymers, i. the polymers containing at least one monomer unit from the group of acrylic acid and / or methacrylic acid and / or esters thereof.
- This acrylate polymer is selected from b1) polyacrylic acid and / or b2) copolymers of methacrylic acid with acrylamidopropanesulfonic acid and / or b3) copolymers of acrylic acid with methacrylic acid and acrylic esters and / or b4) copolymers of acrylic acid with methacrylic acid with acrylic acid esters and
- Methacrylic acid esters and / or b5) copolymers of acrylic acid esters with methacrylic acid are examples of copolymers of acrylic acid esters with methacrylic acid.
- agents which, based on the weight of the ready-to-use agent, are from 0.05 to 5% by weight, preferably from 0.1 to 4% by weight and in particular from 0.25 to 3% by weight of acrylate Polymer (s) B included.
- agents according to the invention which contain polyacrylic acid as polymer B are preferred. This has structural units of the formula
- agents according to the invention are characterized in that they contain, as polymer b1, polyacrylic acids having a molecular weight of from 10 to 250 kDa, preferably from 25 to 200 kDa, more preferably from 50 to 150 kDa and in particular from 70 to 100 kDa.
- the polymers b1 are preferably used within certain quantitative ranges.
- agents according to the invention are preferred which, based on the weight of the ready-to-use agent, 0.05 to 5 wt .-%, preferably 0.1 to 4 wt .-% and in particular 0.25 to 3 wt .-% polymer (e ) b1 included.
- the agents according to the invention may also contain polymers b2 from the group of copolymers of methacrylic acid with acrylamidopropanesulfonic acid.
- indices m and n vary depending on the molecular weight of the polymer and should not mean that they are block copolymers. Rather, structural units can be present in the molecule in a statistically distributed manner.
- Particularly preferred agents according to the invention are characterized in that they contain copolymer b2 copolymers of methacrylic acid with acrylamidopropanesulfonic acid having a molecular weight of 100 to 2500 kDa, preferably from 250 to 2000 kDa, more preferably from 500 to 1750 kDa and in particular from 800 to 1500 kDa ,
- the copolymers b2 are used within certain ranges.
- agents according to the invention are preferred which, based on the weight of the ready-to-use agent, 0.05 to 5 wt .-%, preferably 0.1 to 4 wt .-% and in particular 0.25 to 3 wt .-% copolymer (e ) b2 included.
- Copolymers of methacrylic acid and acrylamidopropanesulfonic acid for example, under the trade name Fixomer ® A-30 (Nalco) available.
- R1 is -H or -CH 3.
- Particularly preferred agents according to the invention are characterized in that they contain copolymer b3 copolymers of acrylic acid with methacrylic acid and acrylic esters having a molar mass of 50 to 500 kDa, preferably 100 to 400 kDa, more preferably 150 to 300 kDa and especially 200 to 250 kDa , contain.
- the copolymers b3 are used within certain ranges.
- agents according to the invention are preferred which, based on the weight of the ready-to-use agent, 0.05 to 5 wt .-%, preferably 0.1 to 4 wt .-% and in particular 0.25 to 3 wt .-% copolymer (e ) b3.
- a very particularly preferred copolymer b3 is referred to as INCI nomenclature as acrylate copolymer.
- Such a polymer is available for example under the trade name Aculyn ® 33A (Rohm & Haas).
- the agents according to the invention may also comprise polymers b4 from the group of copolymers of acrylic acid with methacrylic acid and ethoxylated acrylic acid esters and ethoxylated methacrylic acid esters.
- R 1 is a methyl group
- R is a hydrocarbon radical having one to 22 C atoms
- x is from 1 to 50.
- Particularly preferred agents according to the invention are characterized in that they contain as copolymer b4 copolymers of acrylic acid with methacrylic acid and ethoxylated acrylic acid esters and ethoxylated methacrylic acid esters having a molecular weight of 100 to 500 kDa, preferably 150 to 400 kDa, more preferably 200 to 300 kDa and especially of 225 to 275 kDa, included.
- the copolymers b4 are used within certain ranges.
- agents according to the invention are preferred which, based on the weight of the ready-to-use agent, 0.05 to 5 wt .-%, preferably 0.1 to 4 wt .-% and in particular 0.25 to 3 wt .-% copolymer (e ) b4 included.
- An especially preferred copolymer b4 has 25 EO units, is esterified with behenyl alcohol and is designated according to the INCI nomenclature as acrylates / beheneth-25 methacrylate copolymer.
- Such a polymer is, for example, under the trade name Aculyn ® 28 (Rohm & Haas).
- the agents according to the invention may also be used Contain polymers b5 from the group of copolymers of acrylic acid esters with methacrylic acid.
- Preferred acrylic acid esters are methyl acrylate and ethyl acrylate, with the latter being particularly preferred.
- Particularly preferred agents according to the invention are characterized in that they contain copolymer b5 copolymers of acrylic acid esters with methacrylic acid having a molecular weight of 100 to 500 kDa, preferably from 150 to 400 kDa, more preferably from 200 to 300 kDa and in particular from 225 to 275 kDa ,
- the copolymers b5 are used within certain ranges.
- agents according to the invention are preferred which, based on the weight of the ready-to-use agent, 0.05 to 5 wt .-%, preferably 0.1 to 4 wt .-% and in particular 0.25 to 3 wt .-% copolymer (e ) b5 included.
- a particularly preferred copolymer b5 is derived from the polymerization of methacrylic acid with ethyl acrylate and is referred to as an acrylate copolymer according to the INCI nomenclature. Such a polymer is available, for example under the trade name Luviflex® ® Soft (BASF).
- the agents according to the invention preferably comprise as a further ingredient a film-forming polymer.
- Particularly preferred agents according to the invention contain, based on their weight, from 0.1 to 25% by weight of at least one film former.
- Particularly preferred film formers which can be used in the compositions according to the invention are described below.
- Particularly preferred agents according to the invention are characterized in that they comprise at least one further copolymer C which contains at least one structural unit of the formula (CI) and at least one structural unit of the formula (C-II),
- R is a C 1 to C 30 alkyl group, a C 1 to C 4 aralkyl group, a C 2 to C 6 alkenyl group or a C 2 to C 6 hydroxyalkyl group, and
- n 1, 2 or 3 as the number of methylene units.
- Film-forming and / or consolidating copolymers C are known. These copolymers have at least one structural unit of the formula (C-I) and at least one structural unit of the formula (C-II) and may moreover comprise further structural units which are copolymerized by the addition of corresponding monomers during the polymerization.
- Preferred groups R are, for example, -CH 3 ; -CH 2 CH 3 , -CH 2 CH 2 CH 3 , CH (CH 3 ) 2 , - (CH 2 ) 3 CH 3 ,
- X " represents a physiologically acceptable anion, preferred anions are chloride, bromide, iodide, sulfate, methosulfate, ethyl sulfate, tosylate and tetrafluoroborate.
- n is the number of methylene groups.
- Particularly preferred agents according to the invention are characterized in that they contain as copolymer C a copolymer C1 which contains at least one structural unit of the formula (C-I) and at least one structural unit of the formula (C-II),
- Very particularly preferred copolymers C1 contain 10 to 30 mol%, preferably 15 to 25 mol% and in particular 20 mol% of structural units of the formula (CI) and 70 to 90 mol%, preferably 75 to 85 mol. % and in particular 80 mol .-% of structural units according to formula (C-II).
- the copolymers C1 contain not more than 5% by weight, preferably not more than 1% by weight, Contain polymer units, which are due to the incorporation of other monomers.
- the copolymers C1 are composed exclusively of structural units of the formula (C-I) and (C-II) and can be represented by the general formula
- indices m and n vary depending on the molecular weight of the polymer and should not mean that they are block copolymers. Rather, structural units of the formula (CI) and the formula (C-II) can be present in the molecule in a statistically distributed manner.
- Particularly preferred agents according to the invention contain a copolymer C1 which has molecular weights within a certain range.
- agents according to the invention are preferred in which the copolymer A1 has a molecular weight of from 50 to 400 kDa, preferably from 100 to 300 kDa, more preferably from 150 to 250 kDa and in particular from 190 to 210 kDa.
- compositions according to the invention may also contain copolymers C2 which have structural units of the formula (C-II) in which n is the number 3 as additional structural units.
- copolymers C2 which have structural units of the formula (C-II) in which n is the number 3 as additional structural units.
- the copolymers C2 in addition to polymer units resulting from the incorporation of said structural units of the formula (CI) and (C-II) in the copolymer, a maximum of 5 wt .-%, preferably at most 1 wt .-% , Contain polymer units due to the incorporation of other monomers.
- the copolymers C2 are composed exclusively of structural units of the formula (CI) and (C-II) and can be represented by the general formula
- N-methylvinylimidazole / vinylpyrrolidone / vinyl caprolactam copolymers are referred to as Polyquaternium-46, according to INCI nomenclature and are obtainable for example under the trade name Luviquat Hold ® from BASF.
- Particularly preferred agents according to the invention comprise a copolymer C2 which has molecular weights within a certain range.
- agents according to the invention are preferred in which the copolymer C2 has a molecular weight of from 100 to 1000 kDa, preferably from 250 to 900 kDa, more preferably from 500 to 850 kDa and in particular from 650 to 710 kDa.
- the agents according to the invention may also contain copolymers C 3 which have structural units of the formula (C-II) as additional structural units in which n represents the Number 3 stands as well Further distraction units from the group of vinylimidazole units and further structural units from the group of the acrylamide and / or methacrylamide units.
- compositions according to the invention are characterized in that they contain as copolymer C a copolymer C3 which has at least one structural unit of the formula (CI) and at least one structural unit of the formula (C-II) and at least one structural unit of the formula (C-III) and contains at least one structural unit of the formula (C-IV),
- the copolymers C3 in addition to polymer units resulting from the incorporation of said structural units of the formula (CI), (C-II), (C-III) and (C-IV) in the copolymer, a maximum of 5 Wt .-%, preferably at most 1 wt .-%, polymer units, which go back to the incorporation of other monomers.
- the copolymers C3 are composed exclusively of structural units of the formula (CI), (C-II), (C-III) and (C-IV) and can be represented by the general formula
- N-methylvinylimidazole / Vinylpyrrolidon ⁇ / inylimidazol / methacrylamide copolymers as Polyquaternium-68, according to INCI nomenclature and are obtainable for example under the trade name Luviquat ® Supreme by BASF.
- compositions according to the invention contain a copolymer C3 which has molecular weights within a certain range.
- agents according to the invention are preferred in which the copolymer A3 has a molecular weight of 100 to 500 kDa, preferably from 150 to 400 kDa, more preferably from 250 to 350 kDa and in particular from 290 to 310 kDa.
- agents according to the invention are preferred in which the total amount of copolymers C, based on the weight of the ready-to-use agent, 0.05 to 5 wt .-%, preferably 0.1 to 4 wt .-% and in particular 0.25 to 3 wt .-%, is.
- compositions according to the invention may contain at least one further copolymer D from the group of acrylate polymers formed from at least one monomer d1 selected from acrylic acid and / or methacrylic acid, and at least one monomer d2 selected from acrylamide and or methacrylamide and at least one monomer d3 selected from N-substituted acrylamides and / or methacrylamides.
- This copolymer D comprises at least one monomer d1 selected from acrylic acid and / or methacrylic acid, and at least one monomer d2 selected from acrylamide and / or methacrylamide and at least one monomer d3 selected from N-substituted acrylamides and / or methacrylamides and may further comprise further structural units , which are copolymerized by the addition of appropriate monomers in the polymerization.
- copolymers D are copolymers of
- Acrylic acid and acrylamide and N-substituted acrylamides Acrylic acid and methacrylamide and N-substituted acrylamides Methacrylic acid and acrylamide and N-substituted acrylamides
- Copolymer D contain a copolymer D1 which comprises, as monomer d1, acrylic acid.
- a preferred monomer is the acrylamide.
- preferred agents according to the invention are characterized in that they contain, as copolymer D, a copolymer D1 which comprises acrylamide as monomer d2.
- N-substitution on the N-substituted acrylamides may be by simple alkali groups (preferably methyl, ethyl, n-propyl, isoporphyl), but particularly preferred are substituted alkyl groups bearing anionic functionalities. Very particular preference is given to sulfonate-containing substituents.
- a particularly preferred agent according to the invention is characterized in that it contains as copolymer D a copolymer D1 which comprises acryloyldimethyltaurate as monomer d3.
- copolymers E1 can be defined by the general formula
- indices m, n and o vary depending on the molecular weight of the polymer and should not mean that they are block copolymers. Rather, structural units can be present in the molecule in a statistically distributed manner.
- Particularly preferred agents according to the invention are characterized in that the copolymer D1 has a molecular weight of from 50 to 500 kDa, preferably from 100 to 450 kDa, more preferably from 150 to 400 kDa and in particular from 200 to 300 kDa.
- the copolymers D are used within certain ranges.
- agents according to the invention are preferred in which the total amount of copolymers D, based on the weight of the ready-to-use agent, 0.05 to 5 wt .-%, preferably 0.1 to 4 wt .-% and in particular 0.25 to 3 wt .-% is.
- Copolymers of acrylamide with methacrylic acid and acryloyldimethyltaurate are available for example under the trade name Acudyne ® SCP (Rohm & Haas).
- compositions according to the invention may contain further film-forming polymers E.
- Preferred agents according to the invention comprise at least one copolymer E selected from e1) copolymers of vinylpyrrolidone with methacrylamidopropyltrimethylammonium chloride (MAPTAC) and / or e2) copolymers of vinylpyrrolidone with dimethylaminoethyl methacrylate and / or e3) Copolymers of vinylpyrrolidone with dimethylaminopropylnethacrylannide and alkyldimethylpropylmethacrylamidoammonium salts.
- MATAC methacrylamidopropyltrimethylammonium chloride
- agents according to the invention which contain, as polymer E, copolymers of vinylpyrrolidone with methacrylamidopropyltrimethylammonium chloride (MAPTAC) (e1).
- MATAC methacrylamidopropyltrimethylammonium chloride
- indices m and n vary depending on the molecular weight of the polymer and should not mean that they are block copolymers. Rather, structural units can be present in the molecule in a statistically distributed manner.
- Particularly preferred agents according to the invention are characterized in that they contain, as cationic polymer e1, copolymers of methacrylamidopropyltrimethylammonium chloride (MAPTAC) with vinylpyrrolidone, which contain 40 to 95 mol%, preferably 42.5 to 90 mol%, more preferably 45 to 85 mol .-% and in particular 50 to 80 mol .-% vinylpyrrolidone.
- MATERC methacrylamidopropyltrimethylammonium chloride
- copolymers e1 have molecular weights of from 10 to 1000 kDa, preferably from 25 to 900 kDa, more preferably from 50 to 800 kDa and in particular from 100 to 750 kDa.
- the copolymers e1 are used within certain ranges.
- agents according to the invention are preferred which, based on the weight of the ready-to-use agent, 0.05 to 5 wt .-%, preferably 0.1 to 4 wt .-% and in particular 0.25 to 3 wt .-% copolymer (e ) e1 included.
- a very particularly preferred copolymer e1 is designated as Polyquaternium-28 according to the INCI nomenclature. Such a polymer is available, for example under the trade name Gafquat ® HS-100 (ISP).
- the agents according to the invention may also contain polymers e2 from the group of copolymers of vinylpyrrolidone with dimethylaminoethyl methacrylate. These can be explained by the general formula
- indices m and n vary depending on the molecular weight of the polymer and should not mean that they are block copolymers. Rather, structural units can be present in the molecule in a statistically distributed manner.
- Particularly preferred agents according to the invention are characterized in that they contain, as cationic polymer e2, copolymers of vinylpyrrolidone with dimethylaminoethyl methacrylate, containing 40 to 95 mol%, preferably 42.5 to 90 mol%, more preferably 45 to 85 mol%. and in particular 50 to 80 mol .-% vinylpyrrolidone.
- copolymers e2 have molecular weights of from 100 to 2500 kDa, preferably from 250 to 2000 kDa, more preferably from 500 to 1750 kDa and in particular from 800 to 1500 kDa.
- copolymers e2 are preferably used within certain quantitative ranges.
- agents according to the invention are preferred which, based on the weight of the ready-to-use agent, 0.05 to 5 wt .-%, preferably 0.1 to 4 wt .-% and in particular 0.25 to 3 wt .-% copolymer (e ) f2 included.
- a particularly preferred copolymer e2 is referred to according to the INCI nomenclature as Polyquaternium-11.
- Such a polymer is available for example under the trade name Gafquat ® 755 N (ISP).
- the agents according to the invention may also contain polymers e3 from the group of copolymers of vinylpyrrolidone with dimethylaminopropylmethacrylamide and alkyldimethylpropylmethacrylamidoammonium salts.
- Particularly preferred agents according to the invention are characterized in that they contain as cationic polymer e3 copolymers of vinylpyrrolidone with dimethylaminopropylmethacrylamide and lauryldimethylpropylmethacrylamidoammonium salts.
- Particularly preferred agents according to the invention are further characterized in that they contain as the cationic polymer e3 copolymers of vinylpyrrolidone with dimethylaminopropylmethacrylamide and Alkyldimethylpropylmethacrylamidoammoniumsalzen which 40 to 95 mol .-%, preferably 42.5 to 90 mol .-%, more preferably 45 to 85 mol .-% and in particular 50 to 80 mol .-% vinylpyrrolidone.
- the cationic polymer e3 copolymers of vinylpyrrolidone with dimethylaminopropylmethacrylamide and Alkyldimethylpropylmethacrylamidoammoniumsalzen which 40 to 95 mol .-%, preferably 42.5 to 90 mol .-%, more preferably 45 to 85 mol .-% and in particular 50 to 80 mol .-% vinylpyrrolidone.
- Very particularly preferred agents according to the invention are additionally characterized in that the copolymers e3 have molecular weights of from 10 to 1000 kDa, preferably from 25 to 900 kDa, more preferably from 50 to 800 kDa and in particular from 100 to 750 kDa
- copolymers e3 are preferably used within certain quantitative ranges.
- agents according to the invention are preferred which, based on the weight of the ready-to-use agent, 0.05 to 5 wt .-%, preferably 0.1 to 4 wt .-% and in particular 0.25 to 3 wt .-% copolymer (e ) e3 included.
- a very particularly preferred copolymer e3 is designated according to the INCI nomenclature as Polyquaternium-55. Such a polymer is available, for example under the trade name Styleze® ® W20 (ISP).
- the total polymer content of the compositions is 1 to 15% by weight, preferably 2.5 to 12.5% by weight, more preferably 4 to 10% by weight and in particular 5 to 8% by weight.
- compositions according to the invention may contain at least one silicone oil and / or silicone gum.
- Preferred agents according to the invention are characterized in that they comprise at least one silicone, preferably a silicone, selected from:
- polyalkyl siloxanes polyaryl siloxanes, polyalkylaryl siloxanes which are volatile or nonvolatile, straight chain, branched or cyclic, crosslinked or uncrosslinked;
- grafted silicone polymers having a non-silicone organic backbone consisting of an organic backbone formed from organic monomers containing no silicone grafted with at least one polysiloxane macromer in the chain and optionally at least one chain end;
- grafted polysiloxane backbone silicone polymers having grafted thereto non-silicone organic monomers having a polysiloxane backbone onto which at least one organic macromer not containing silicone has been grafted in the chain, and optionally at least at one of its ends ; or their mixtures.
- compositions according to the invention comprise the silicone (s) preferably in amounts of from 0.1 to 10% by weight, preferably from 0.25 to 7% by weight and in particular from 0.5 to 5% by weight. , in each case based on the total mean.
- Silicone oils or silicone gums which are suitable according to the invention are in particular dialkyl and alkylaryl siloxanes, for example dimethylpolysiloxane and methylphenylpolysiloxane, and also their alkoxylated, quaternized or else anionic derivatives. Preference is given to cyclic and linear polydialkylsiloxanes, their alkoxylated and / or aminated derivatives, dihydroxypoly-dimethylsiloxanes and polyphenylalkylsiloxanes. Silicone oils cause a wide variety of effects. For example, at the same time they influence the dry and wet combability, the grip of dry and wet hair and the shine.
- silicone oils is understood by the person skilled in the art as meaning several structures of silicon-organic compounds. Initially, these are understood to mean the dimethiconols (S1). These may be both linear and branched as well as cyclic or cyclic and branched.
- the molecular weights of the dimethiconols are between 1,000 D and 10000000 D.
- the viscosities are between 100 and 10,000,000 cPs measured at 25 0 C by means of a glass capillary viscometer according to Dow Corning Corporate Test Method CTM 0004 dated 20 July 1970.
- Preferred viscosities are from 1000 to 5,000,000 cPs, most preferred viscosities are between 10,000 and 3,000,000 cps. The most preferred range is between 50,000 and 2,000,000 cps.
- Examples of such products include the following commercial products: Botanisil NU-150M (Botanigenics), Dow Coming 1-1254 Fluid, Dow Corning 2-9023 Fluid, Dow Corning 2-9026 Fluid, Ultrapure Dimethiconol (Ultra Chemical), Unisil SF- R (Universal Preserve), X-21-5619 (Shin-Etsu Chemical Co.), Abil OSW 5 (Degussa Care Speciales), ACC DL-9430 Emulsion (Taylor Chemical Company), AEC Dimethiconol & Sodium Dodecylbenzenesulfonate (A & E Connock (Perfumery & Cosmetics) Ltd.), BC Dimethiconol Emulsion 95 (Basildon Chemical Company, Ltd.), Cosmetic Fluid 1401, Cosmetic Fluid 1403, Cosmetic Fluid 1501, Cosmetic Fluid 1401 DC (all aforementioned Chemsil Silicones, Inc.), Dow Corning 1401 Fluid, Dow Corning 1403 Fluid, Dow Corning 1501 Fluid, Dow Corning 1784 H
- Dimethicones form the second group of silicones which may be present according to the invention. These may be both linear and branched as well as cyclic or cyclic and branched.
- the molecular weights of Dimethicone lie between 1,000 D and 10000000 D.
- the viscosities are between 100 and 10,000,000 cPs measured at 25 0 C by means of a glass capillary viscometer according to Dow Corning Corporate Test Method CTM 0004 dated 20 July 1970.
- Preferred viscosities are between 1,000 and 5,000,000 cPs, particularly preferred viscosities are between 10,000 and 3,000,000 cPs. Most preferably, the viscosity is in the range between 50,000 and 200,000 cps.
- Dimethicone copolyols (S3) form another group of silicones that are suitable. Dimethicone copolyols can be represented by the following structural formulas:
- Branched dimethicone copolyols can be represented by the structural formula (S3-III):
- the radicals R 1 and R 2 are each independently hydrogen, a methyl radical, a C 2 to C 30 linear, saturated or unsaturated hydrocarbon radical, a phenyl radical and / or an aryl radical.
- the groups represented by R 1 and R 2 include alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, isopentyl, neopentyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals, and sulfur-containing radicals such as mer
- PE stands for a polyoxyalkylene radical.
- Preferred polyoxyalkylene radicals are derived from ethylene oxide, propylene oxide and glycerol.
- the numbers x, y and z are integers and each run independently from 0 to 50,000.
- the molecular weights of Dimethicone lie between 1,000 D and 10000000 D.
- the viscosities are between 100 and 10,000,000 cPs measured at 25 0 C by means of a glass capillary viscometer according to Dow Corning Corporate Test Method CTM 0004 dated 20 July 1970.
- Preferred viscosities are 1000-5000000 cPs, most preferred viscosities are between 10,000 and 3,000,000 cps. The most preferred range is between 50,000 and 2,000,000 cps.
- Corresponding dimethicone copolyols are commercially available and are sold, for example, by Dow Corning under the name Dow Corning® 5330 Fluid.
- Suitable silicones are furthermore amino-functional silicones (S4), in particular the silicones which are grouped under the INCI name amodimethicones. These are silicones which have at least one, optionally substituted, amino group.
- Preferred amino-functional silicones correspond to the formula (S4-1)
- G is -H, a phenyl group, -OH, -O-CH 3 , -CH 3 , -CH 2 CH 3 , -CH 2 CH 2 CH 3 , -CH (CH 3 ) 2 , -CH 2 CH 2 CH 2 CH 3 , -CH 2 CH (CH 3 ) 2 , -CH (CH 3 ) CH 2 CH 3 , -C (CH 3 ) 3 ;
- a is a number between 0 and 3, in particular 0;
- b is a number between 0 and 1, in particular 1,
- m and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n preferably values from 0 to 1999 and in particular from 49 to
- 149 and m preferably assumes values from 1 to 2000, in particular from 1 to 10,
- R - R ' is a monovalent radical selected from -N (R ") - CH 2 -CH 2 - N (R") 2, -N (R ") 2, -N + (R") 3 A ", -N + H (R ") 2 A “ , -N + H 2 (R ") A “ , -N (R ”) - CH 2 -CH 2 -N + R” H 2 A “ , where each R" is the same or different radicals from the group -H, -phenyl, -.
- benzyl the C 20 -alkyl, preferably -CH 3, -CH 2 CH 3, -CH 2 CH 2 CH 3, -CH (CH 3) 2, - CH 2 CH 2 CH 2 CH 3 , -CH 2 CH (CH 3 ) 2 , -CH (CH 3 ) CH 2 CH 3 , -C (CH 3 ) 3 , and
- A represents an anion which is preferably selected from chloride, bromide, iodide or methosulfate.
- Particularly preferred amino-functional silicones correspond to the formula (S4 - II)
- m and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n is preferably values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10.
- silicones are referred to as trimethylsilylamodimethicones according to the INCI declaration.
- amino-functional silicones of the formula (S4-IM) wherein R is -OH, -O-CH 3 or a -CH 3 group and m, n1 and n2 are numbers whose sum (m + n1 + n2) is between 1 and 2,000, preferably between 50 and 150, wherein the sum (n1 + n2) preferably assumes values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10.
- silicones are referred to as amodimethicone according to the INCI nomenclature and are available for example in the form of an emulsion as a commercial product Dow Corning ® 949 in a mixture with a cationic and a nonionic surfactant.
- those amino-functional silicones are used which have an amine number above 0.25 meq / g, preferably above 0.3 meq / g and especially preferably above 0.4 meq / g.
- the amine number stands for the milliequivalents of amine per gram of the amino-functional silicone. It can be determined by titration and also expressed in mg KOH / g.
- oligomeric polydimethylcyclosiloxanes (INCI name: cyclomethicone), in particular the tetrameric and pentameric compounds sold as commercial products DC 245 Fluid, DC 344 and DC 345, respectively, by Dow Corning,
- Hexamethyldisiloxane (INCI name: hexamethyldisiloxane), eg. B. the product sold under the name Abil ® K 520,
- anionic silicone oils such as the Dow Corning® 1784 product.
- compositions of the invention contain the polymers in a cosmetically acceptable carrier.
- Preferred cosmetically acceptable carriers are aqueous, alcoholic or aqueous-alcoholic media with preferably at least 10% by weight of water, based on the total agent.
- alcohols it is possible in particular to include the lower alcohols having 1 to 4 carbon atoms usually used for cosmetic purposes, such as, for example, ethanol and isopropanol.
- co-solvents are unbranched or branched hydrocarbons such as pentane, hexane, isopentane and cyclic hydrocarbons such as cyclopentane and cyclohexane.
- particularly preferred water-soluble solvents are glycerol, ethylene glycol, butylene glycol and propylene glycol in an amount of up to 30 wt .-% based on the total agent.
- the agents preferably have a pH of 2 to 11.
- the pH range between 4 and 9 is particularly preferred.
- the pH values in the context of this document refer to the pH at 25 ° C., unless stated otherwise.
- compositions of the invention may further contain the auxiliaries and additives which are usually added to the respective cosmetic products.
- auxiliaries and additives are care substances. These are used both in skin and hair treatment agents and can be incorporated with a suitable choice of the care substance, for example in creams, shampoos, hair conditioners, hair treatments, gels, pump and aerosol sprays and foam products.
- an agent according to the invention may contain, for example, at least one protein hydrolyzate and / or one of its derivatives.
- Protein hydrolysates are product mixtures obtained by acid, alkaline or enzymatically catalyzed degradation of proteins (proteins).
- the molecular weight of the protein hydrolysates which can be used according to the invention is between 75, the molecular weight for glycine, and 200,000, preferably the molecular weight is 75 to 50,000 and very particularly preferably 75 to 20,000 Da Ito n.
- protein hydrolysates of both vegetable and animal or marine or synthetic origin can be used.
- Animal protein hydrolysates are, for example, elastin, collagen, keratin, silk and milk protein protein hydrolysates, which may also be present in the form of salts.
- Such products are, for example, under the trademarks Dehylan ® (Cognis), Promois® ® (Interorgana) Collapuron ® (Cognis), Nutrilan® ® (Cognis), Gelita-Sol ® (German Gelatinefabriken Stoess and Co), Lexein ® (Inolex) sericin (Pentapharm) and kerasol tm ® (Croda) sold.
- the protein hydrolysates are present in the agents according to the invention, for example, in concentrations of from 0.01% by weight to 20% by weight, preferably from 0.05% by weight to 15% by weight and very particularly preferably in amounts of 0 , 05 wt .-% up to 5 wt .-%, each based on the total application preparation included.
- a conditioner of another class of compounds continue cationic surfactants are suitable.
- Cationic surfactants of the quaternary ammonium compound type, the esterquats and the amidoamines are preferred according to the invention.
- Preferred quaternary ammonium compounds are ammonium halides, in particular chlorides and bromides, such as alkyltrimethylammonium chlorides, dialkyldimethylammonium chlorides and trialkylmethylammonium chlorides, for example cetyltrimethylammonium chloride, stearyltrimethylammonium chloride, distearyldimethylammonium chloride, lauryldimethylammonium chloride, lauryldimethylbenzylammonium chloride and tricetylmethylammonium chloride, and those listed under the INCI names Quaternium-27 and quaternium chloride. 83 known imidazolium compounds.
- esterquats are known substances which contain both at least one ester function and at least one quaternary ammonium group as a structural element.
- Preferred esterquats are quaternized ester salts of fatty acids with triethanolamine, quaternized ester salts of fatty acids with diethanolalkylamines and quaternized ester salts of fatty acids with 1,2-dihydroxypropyldialkylamines.
- Such products are marketed under the trade names Stepantex® ®, ® and Dehyquart® Armocare® ®.
- the products Armocare ® VGH-70, a N, N-bis (2-palmitoyloxyethyl) dimethylammonium chloride, as well as Dehyquart ® F-75, Dehyquart ® C-4046, Dehyquart ® L80 and Dehyquart ® AU-35 are examples of such esterquats.
- the alkylamidoamines are usually prepared by amidation of natural or synthetic fatty acids and fatty acid cuts with dialkylaminoamines.
- An inventively particularly suitable compound from this group of substances under the name Tegoamid ® S 18 commercial stearamidopropyl dimethylamine is.
- the cationic surfactants are contained in the compositions according to the invention preferably in amounts of from 0.05 to 10% by weight, based on the total application preparation. Amounts of 0.1 to 5 wt .-% are particularly preferred.
- Nurturing polymers are also suitable as a care substance. It should be noted at this point that some nourishing polymers also have film-forming and / or setting properties, and may therefore also be mentioned in the list of suitable film-forming and / or setting polymers.
- a first group of caring polymers are the cationic polymers.
- Cationic polymers are to be understood as meaning polymers which have a group in the main and / or side chain which may be “temporary” or “permanent” cationic.
- “permanently cationic” refers to those polymers which have a cationic group, irrespective of the pH of the agent. These are usually polymers containing a quaternary nitrogen atom, for example in the form of an ammonium group.
- Preferred cationic groups are quaternary ammonium groups.
- those polymers in which the quaternary Ammoniunnoli are bonded via a CI_ 4 hydrocarbon group to a synthesized from acrylic acid, methacrylic acid or derivatives thereof, polymer backbone have been found to be particularly suitable.
- R 1 -H or -CH 3
- R 2 , R 3 and R 4 are independently selected from C-
- m 1, 2, 3 or 4
- n is a natural number
- X ' is a physiologically acceptable organic or inorganic anion, as well as copolymers consisting essentially of the in formula (G1 -I) and nonionic monomer units, are particularly preferred cationic polymers.
- those are preferred according to the invention for which at least one of the following conditions applies: R 1 is a methyl group, R 2 , R 3 and R 4 are methyl groups, m is 2.
- Suitable physiologically tolerable counterions X " include, for example, halide ions, sulfate ions, phosphate ions, methosulfate ions and organic ions such as lactate, citrate, tartrate and acetate ions, preference being given to halide ions, in particular chloride.
- a particularly suitable homopolymer is, if desired, crosslinked, poly (meth acryloyloxyethyltrimethylammonium chloride) with the INCI name Polyquaternium-37.
- the crosslinking can be carried out with the aid of poly olefinically unsaturated compounds, for example divinylbenzene, tetraallyloxyethane, methylenebisacrylamide, diallyl ether, polyallylpolyglyceryl ethers, or allyl ethers of sugars or sugar derivatives such as erythritol, pentaerythritol, arabitol, mannitol, sorbitol, sucrose or glucose.
- Methylenebisacrylamide is a preferred crosslinking agent.
- the homopolymer is preferably used in the form of a non-aqueous polymer dispersion which should not have a polymer content of less than 30% by weight.
- Such polymer dispersions are (under the names Salcare ® SC 95 about 50% polymer content, additional components: mineral oil (INCI name: Mineral Oil) and tridecyl-polyoxypropylene-polyoxyethylene-ether (INCI name: PPG-1 trideceth-6) ) and Salcare ® SC 96 (about 50% polymer content, additional components: mixture of diesters of propylene glycol (with a mixture of caprylic and capric acid INCI name: propylene glycol Dicaprylate / Dicaprate) and tridecyl polyoxypropylene-polyoxyethylene-ether (INCI name: PPG-1-Trideceth-6)) commercially available.
- Copolymers with monomer units of the formula (G1-I) as the non-ionic monomer preferably acrylamide, methacrylamide, acrylic acid and methacrylic acid alkyl esters CI_ 4-C- ⁇ - 4 -alkyl.
- the acrylamide is particularly preferred.
- These copolymers can also be crosslinked, as described above in the case of the homopolymers.
- a copolymer preferred according to the invention is the crosslinked acrylamide-methacryloyloxyethyltrimethylammonium chloride copolymer.
- Such copolymers in which the monomers are present in a weight ratio of about 20:80, are commercially available as approximately 50% non-aqueous polymer dispersion 92 under the name Salcare ® SC.
- cationic polymers are for example quaternised CeIIu lose-derivatives, such as are available under the names of Celquat ® and Polymer JR ® commercially.
- the compounds Celquat ® H 100, Celquat ® L 200 and Polymer JR ® 400 are preferred quaternized cellulose derivatives, cationic alkyl polyglycosides according to DE-PS 44 13 686, cationized honey, for example the commercial product Honeyquat ® 50, cationic guar derivatives, such as in particular the products sold under the trade names Cosmedia® ® guar and Jaguar ® products,
- Quaternary group polysiloxanes such as the commercially available products Q2-7224 (manufactured by Dow Corning, a stabilized trimethylsilylamodimethicone), Dow Corning® 929 emulsion (containing a hydroxylamino-modified silicone, also referred to as amodimethicones), SM -2059 (manufacturer: General Electric), SLM-55067 (manufacturer: Wacker) and Abil ® -Quat 3270 and 3272 (manufacturer: Th Goldschmidt.), diquaternary polydimethylsiloxanes, quaternium-80), polymeric dimethyldiallylammonium salts and their copolymers with esters and amides of acrylic acid and methacrylic acid.
- Q2-7224 manufactured by Dow Corning, a stabilized trimethylsilylamodimethicone
- Dow Corning® 929 emulsion containing a hydroxylamino-modified silicone, also referred
- Merquat ® 100 Poly (dimethyldiallylammonium chloride)
- Merquat ® 550 dimethyldiallylammonium chloride-acrylamide copolymer
- cationic polymers quaternized polyvinyl alcohol, as well as by the names of Polyquaternium 2, Polyquaternium 17, Polyquaternium 18 and Polyquaternium 27 known polymers with quaternary nitrogen atoms in the polymer main chain.
- cationic polymers which can be used according to the invention are the so-called "temporary cationic" polymers. These polymers usually contain an amino group which, at certain pH values, is present as quaternary ammonium group and thus cationic. Preferred are for example, chitosan and its derivatives, as they are freely available commercially, for example, under the trade names Hydagen ® CMF, Hydagen ® HCMF, Kytamer ® PC and Chitolam ® NB / 101.
- amphoteric polymers are those polymers which are composed essentially
- R 1 -CH CR 2 -CO-Z- (C n H 2n ) -N (+) R 3 R 4 R 5 A () (II) in which R 1 and R 2 independently of one another represent hydrogen or a methyl group and R 3 , R 4 and R 5 are each independently an alkyl group of 1 to 4 carbon atoms, Z is an NH group or an oxygen atom, n is an integer of 2 to 5 and A is the anion of an organic or inorganic acid, and
- R 6 -CH CR 7 -COOH (IM) in which R 6 and R 7 independently of one another represent hydrogen or a methyl group.
- These compounds can be used both directly and in salt form, which is obtained by neutralization of the polymers, for example with an alkali metal hydroxide, according to the invention.
- Very particular preference is given to those polymers in which monomers of the type (a) are used in which R 3 , R 4 and R 5 are methyl groups, Z is an NH group and A () is a halide, methoxysulfate or ethoxysulfate ion is; Acrylamidopropyltrimethylammonium chloride is a particularly preferred monomer (a).
- Acrylic acid is preferably used as monomer (b) for the stated polymers.
- the agents according to the invention preferably contain the caring, cationic and / or amphoteric polymers in an amount of from 0.01 to 5% by weight, in particular in an amount of from 0.1 to 2% by weight, in each case based on the total application preparation.
- Further preferred agents according to the invention are characterized in that they additionally care substance (s) - in terms of their weight - in amounts of 0.001 to 10 wt .-%, preferably 0.005 to 7.5 wt .-%, particularly preferably 0.01 to 5 wt .-% and in particular 0.05 to 2.5 wt .-%, with preferred care substance (s) are selected from the group L-carnitine and / or its salts; Panthenol and / or panthothenic acid; the 2-furanones and / or their derivatives (especially pantolactone); Taurine and / or its salts; niacinamide; ubiquinone; Ectoin; Allantoin.
- preferred care substance (s) are selected from the group L-carnitine and / or its salts; Panthenol and / or panthothenic acid; the 2-furanones and / or their derivatives (especially pantolactone); Taurine and / or its salts; n
- L-carnitine (IUPAC name (R) - (3-carboxy-2-hydroxypropyl) -N, N, N-trimethylammonium hydroxide) is a naturally occurring, vitamin-like substance.
- L-carnitine derivatives which are preferred according to the invention are in particular selected from acetyl-L- Carnitine, L-carnitine fumarate, L-carnitine citrate, lauroyl L-carnitine, and most preferably L-carnitine tartrate.
- the L-carnitine compounds mentioned are available, for example, from Lonza GmbH (Wuppertal, Germany).
- Preferred agents according to the invention are characterized in that they contain from -0.001 to 10% by weight, preferably 0.005 to 7.5% by weight, particularly preferably 0.01 to 5% by weight and in particular 0.05% by weight contain up to 2.5 wt .-% L-carnitine or L-carnitine derivatives, with preferred L-carnitine derivatives are selected from acetyl-L-carnitine, L-carnitine fumarate, L-carnitine citrate, lauroyl-L-carnitine and in particular L-carnitine tartrate.
- Panthenol (ILJPAC name: (+) - (R) -2,4-dihydroxy-N- (3-hydroxypropyl) -3,3-dimethylbutyramide) is converted to pantothenic acid in the body.
- Pantothenic acid is a vitamin from the group of B vitamins (vitamin B5).
- Preferred agents according to the invention are characterized in that they contain -0.01 to 5% by weight, preferably 0.05 to 2.5% by weight, more preferably 0.1 to 1.5% by weight, based on their weight. % and in particular 0.25 to 1 wt .-% of panthenol (( ⁇ ) - 2,4-dihydroxy- ⁇ / - (3-hydroxypropyl) -3,3-dimethyl-butyramide).
- Agents preferred according to the invention contain, based on their weight, from 0.01 to 15% by weight, preferably from 0.025 to 12.5% by weight, particularly preferably from 0.05 to 10% by weight, more preferably from 0.1 to 7 , 5 wt .-% and in particular 0.5 to 5 wt .-% taurine (2-aminoethanesulfonic acid).
- compositions of the invention are vitamins, provitamins or vitamin precursors. These are described below:
- agents according to the invention are preferred which, based on their weight, are 0.1 to 5% by weight, preferably 0.2 to 4% by weight, more preferably 0.25 to 3.5% by weight, more preferably 0.5 to 3 wt .-% and in particular 0.5 to 2.5 wt .-% vitamins and / or ProVitamine and / or vitamin precursors, which are preferably assigned to the groups A, B, C, E, F and H.
- vitamin B 5 2,4,4-dihydroxy- ⁇ / - (3-hydroxypropyl) -3,3-dimethylbutyramide, provitamin B 5 ) and / or pantothenic acid (vitamin B 3 , vitamin B 5 ) and / or niacin, Niacinamide or nicotinamide (vitamin B 3 ) and / or L-ascorbic acid (vitamin C) and / or thiamine (vitamin B 1 ) and / or riboflavin (vitamin B 2 , vitamin G) and / or biotin (vitamin B 7 , vitamin H) and / or folic acid (vitamin B 9 , vitamin B c or vitamin M) and / or vitamin B 6 and / or vitamin B 12 included.
- Certain quinones have particular suitability as a care enhancer.
- Particularly preferred agents according to the invention are characterized in that they contain as care substance - based on their weight - 0.0001 to 1 wt .-%, preferably 0.001 to 0.5 wt .-% and particularly preferably 0.005 to 0.1 wt .-% at least one ubiquinone and / or contain at least one ubiquinol and / or at least one derivative of these substances, preferred agents containing a ubiquinone of the formula (Ubi)
- n 6, 7, 8, 9 or 10, particularly preferably 10 (coenzyme Q10).
- the agents according to the invention may contain ectoin.
- Ectoine ((4S) -2-methyl-1, 4,5,6-tetrahydropyrimidine-4-carboxylic acid) is a natural product belonging to the group of compatible solutes.
- the agents according to the invention may contain at least one carbohydrate from the group of monosaccharides, disaccharides and / or oligosaccharides.
- preferred hair treatment compositions according to the invention characterized in that they are used as care substance - based on their weight - 0.01 to 5 wt .-%, preferably 0.05 to 4.5 wt .-%, particularly preferably 0.1 to 4 wt. -%, more preferably 0.5 to 3.5 wt .-% and in particular 0.75 to 2.5 wt .-% carbohydrate (s) selected from monosaccharides, disaccharides and / or oligosaccharides containing preferred carbohydrates are selected out
- Monosaccharides in particular D-ribose and / or D-xylose and / or L-arabinose and / or D-glucose and / or D-mannose and / or D-galactose and / or D-fructose and / or sorbose and / or L-fucose and / or L-rhamnose
- Disaccharides in particular sucrose and / or maltose and / or lactose and / or trehalose and / or cellobiose and / or gentiobiose and / or isomaltose.
- the agents according to the invention may contain emulsifiers (F).
- Emulsifiers effect at the phase interface the formation of water- or oil-stable adsorption layers, which protect the dispersed droplets against coalescence and thus stabilize the emulsion.
- Emulsifiers are therefore constructed like surfactants from a hydrophobic and a hydrophilic part of the molecule. Hydrophilic emulsifiers preferably form O / W emulsions and hydrophobic emulsifiers preferably form W / O emulsions.
- An emulsion is to be understood as meaning a droplet-shaped distribution (dispersion) of a liquid in another liquid with the expenditure of energy to create stabilizing phase interfaces by means of surfactants.
- the selection of these emulsifying surfactants or emulsifiers depends on the substances to be dispersed and the respective outer phase and the fineness of the emulsion.
- Emulsifiers which can be used according to the invention are, for example
- Glucosides mixtures of alkyl (oligo) and fatty alcohols for example, the commercially available product ® Montanov 68,
- Sterols are understood to mean a group of steroids which have a hydroxyl group on C-atom 3 of the steroid skeleton and are isolated both from animal tissue (zoosterols) and from vegetable fats (phytosterols). Examples of zoosterols are cholesterol and lanosterol. Examples of suitable phytosterols are ergosterol, stigmasterol and sitosterol. Mushrooms and yeasts are also used to isolate sterols, the so-called mycosterols.
- glucose phospholipids e.g. as lecithins or phosphatidylcholines from e.g. Egg yolk or plant seeds (e.g., soybeans) are understood.
- Fatty acid esters of sugars and sugar alcohols such as sorbitol
- Polyglycerols and polyglycerol derivatives such as polyglycerol poly-12-hydroxystearate (commercial product Dehymuls ® PGPH),
- Linear and branched fatty acids with 8 to 30 C atoms and their Na, K, ammonium, Ca, Mg and Zn salts.
- the agents according to the invention preferably contain the emulsifiers in amounts of 0.1-25% by weight, in particular 0.5-15% by weight, based on the total agent.
- the compositions according to the invention may preferably comprise at least one nonionic emulsifier contain an HLB value of 8 to 18.
- Nonionic emulsifiers having an HLB value of 10 to 15 may be particularly preferred according to the invention.
- the agent according to the invention may be necessary for them to further contain at least one surfactant. This is especially true for skin cleansers and shampoos. But other means, such as hair rinses, hair treatments and certain styling agents, in particular styling foams, may contain surfactants.
- cationic surfactants can be used, as described above as suitable care agents. With respect to the preferred cationic surfactants and the amounts used, the above statements apply accordingly.
- the agents may contain other surfactants or emulsifiers, with both anionic and ampholytic and nonionic surfactants and all types of known emulsifiers being suitable in principle.
- the group of ampholytic or amphoteric surfactants includes zwitterionic surfactants and ampholytes. The surfactants may already have emulsifying effect.
- Suitable anionic surfactants are in principle all anionic surfactants suitable for use on the human body. These are characterized by a water-solubilizing, anionic group such as. As a carboxylate, sulfate, sulfonate or phosphate group and a lipophilic alkyl group having about 8 to 30 carbon atoms. In addition, glycol or polyglycol ether groups, ester, ether and amide groups and hydroxyl groups may be present in the molecule.
- anionic surfactants are, in each case in the form of the sodium, potassium and ammonium as well as the mono-, di- and trialkanolammonium salts having 2 to 4 C atoms in the alkanol group, linear and branched fatty acids having 8 to 30 C atoms (Soap),
- Ethercarbon Acid the formula RO- (CH2 "CH2 ⁇ ) ⁇ -CH2-COOH, in which R is a linear
- Alkyl group having 8 to 30 C atoms and x 0 or 1 to 16,
- Sulfosuccinic acid mono-alkyl polyoxyethyl esters having 8 to 24 carbon atoms in the alkyl group and 1 to 6 oxyethyl groups, linear alkanesulfonates having 8 to 24 carbon atoms, linear alpha-olefin sulfonates having 8 to 24 carbon atoms,
- Alpha-sulfofatty acid methyl esters of fatty acids having 8 to 30 carbon atoms, - Alkyl sulfates and alkyl polyglycol ether sulfates of the formula RO (CH 2 -CH 2 O) x -OSO 3 H, in which R is a preferably linear alkyl group having 8 to 30 carbon atoms and x 0 or 1 to 12, mixtures of surface-active hydroxysulfonates, sulfated Hydroxyalkylpolyethylen- and / or Hydroxyalkylenpropylenglykolether, sulfonates of unsaturated fatty acids having 8 to 24 carbon atoms and 1 to 6 double bonds, esters of tartaric acid and citric acid with alcohols, the addition products of about 2- 15 molecules of ethylene oxide and / or propylene oxide to fatty alcohols having 8 to 22 Represent C atoms,
- Condensation products of C 8 - C 30 - fatty alcohols with protein hydrolysates and / or amino acids and their derivatives which are known to the skilled person as protein fatty acid condensates, such as Lamepon ® - types Gluadin ® - types Hostapon ® KCG or Amisoft ® - types.
- Preferred anionic surfactants are alkyl sulfates, alkyl polyglycol ether sulfates and ether carboxylic acids having 10 to 18 carbon atoms in the alkyl group and up to 12 glycol ether groups in the molecule, sulfosuccinic acid mono- and dialkyl esters having 8 to 18 carbon atoms in the alkyl group and sulfosuccinic monoalkylpolyoxyethylester with 8 to 18 carbon atoms in the alkyl group and 1 to 6 oxyethyl groups, Monoglycerdisulfate, alkyl and Alkenyletherphosphate and Eiweissfettkladensate.
- Zwitterionic surfactants are those surface-active compounds which carry in the molecule at least one quaternary ammonium group and at least one -COO () or -SO 3 () group.
- Particularly suitable zwitterionic surfactants are the so-called betaines such as N-alkyl-N, N-dimethylammonium glycinates, for example cocoalkyldimethylammonium glycinate, N-acylaminopropyl N, N-dimethylammonium glycinates, for example cocoacylaminopropyldimethylammonium glycinate, and Alkyl-3-carboxymethyl-3-hydroxyethyl-imidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group and Kokosacylaminoethylhydroxyethylcarboxymethylglycinat.
- a preferred zwitterionic surfactant is the fatty acid amide derivative known by the INCI name Cocamidopropyl Betaine.
- Ampholytes are understood as meaning those surface-active compounds which, apart from a C 8 -C 24 -alkyl or -acyl group in the molecule, contain at least one free amino group and at least one -COOH or -SO 3 H group and are capable of forming internal salts.
- ampholytes are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each having about 8 to 24 C atoms in the alkyl group.
- Particularly preferred ampholytes are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and C 12 -C 18 -acylsarcosine.
- Nonionic surfactants contain as hydrophilic group e.g. a polyol group, a polyalkylene glycol ether group, or a combination of polyol and polyglycol ether groups.
- hydrophilic group e.g. a polyol group, a polyalkylene glycol ether group, or a combination of polyol and polyglycol ether groups.
- Such compounds are, for example
- alkylphenols having 8 to 15 carbon atoms in the alkyl group such as those available under the trade names Dehydol ® LS, Dehydol ® LT types (Cognis), C 12 -C 30 fatty acid monoesters and diesters of addition products of 1 to 30 moles of ethylene oxide with glycerol,
- Sugar fatty acid esters and addition products of ethylene oxide with sugar fatty acid esters, addition products of ethylene oxide onto fatty acid alkanolamides and fatty amines Sugar surfactants of the alkyl and alkenyl oligoglycoside type of formula (E4-II), in which R 4 is an alkyl or alkenyl radical having 4 to 22 carbon atoms, G is a sugar radical having 5 or 6 carbon atoms and p is a number from 1 to 10. They can be obtained by the relevant methods of preparative organic chemistry.
- the preferred alkyl and / or alkenyl oligoglycosides are thus alkyl and / or alkenyl oligoglucosides.
- the index number p in the general formula (E4-II) indicates the degree of oligomerization (DP), ie the distribution of mono- and oligoglycosides, and represents a number between 1 and 10.
- the alkyl or alkenyl radical R 4 can be derived from primary alcohols having 4 to 11, preferably 8 to 10 carbon atoms. Alkyl oligoglucosides based on hydrogenated Ci 2 / i 4 coconut alcohol with a DP of 1 to 3
- the preferred nonionic surfactants are the alkylene oxide addition products of saturated linear fatty alcohols and fatty acids having in each case 2 to 30 moles of ethylene oxide per mole of fatty alcohol or fatty acid. Preparations having excellent properties are also obtained if they contain fatty acid esters of ethoxylated glycerol as nonionic surfactants. These connections are identified by the following parameters.
- the alkyl radical R contains 6 to 22 carbon atoms and may be both linear and branched. Preference is given to primary linear and methyl-branched in the 2-position aliphatic radicals.
- alkyl radicals are, for example, 1-octyl, 1-decyl, 1-lauryl, 1-myristyl, 1-cetyl and 1-stearyl. Particularly preferred are 1-octyl, 1-decyl, 1-lauryl, 1-myristyl.
- oxo-alcohols compounds with an odd number of carbon atoms in the alkyl chain predominate.
- the compounds used as surfactant with alkyl groups may each be uniform substances. However, it is generally preferred to use native vegetable or animal raw materials in the production of these substances, so that substance mixtures having different alkyl chain lengths depending on the respective raw material are obtained.
- the other surfactants are generally in amounts of 0.1 to 45 wt .-%, preferably 0.5 to 30 wt .-% and most preferably from 0.5 to 25 wt .-%, based on the respective total Composition, used.
- the amount used depends essentially on the purpose of the agent according to the invention. If it is a shampoo or other cleansing agent, surfactant levels above 45% by weight are also common.
- compositions according to the invention can be carried out in all forms customary for cosmetic products, for example in the form of solutions which can be applied to the skin or hair as facial or hair tonic or pump or aerosol spray, in the form of Creams, emulsions, waxes, gels or surfactant-containing foaming solutions or other preparations which are suitable for use on the skin or hair.
- the agents of the invention are means for temporarily deforming keratinic fibers, i. for styling center I.
- Preferred styling agents are styling gels, pump hair sprays, aerosol hair spray, pumped hair foams and aerosol hair foams.
- Styling gel is in the context of the present application, the generic term for clear or cloudy products, styling waxes, styling creams, styling lotions, styling jellies, etc. Ultimately, this term covers all means for hairdressing hair, which are not hair sprays or foams.
- Hair foams are understood to mean compositions which form a foam when they are removed from a suitable container. It may be necessary to add ingredients to the compositions which promote foaming or stabilize lather once formed.
- surfactants and / or emulsifiers are suitable for this, as have already been described above.
- surfactants from the group of cationic surfactants are used.
- Hair creams and gels generally contain structurants and / or thickening polymers which serve to give the products the desired consistency.
- Structurants and / or thickening polymers are typically used in an amount of from 0.1 to 10% by weight, based on the total product. Amounts of 0.5 to 5 wt .-%, in particular 0.5 to 3 wt .-% are preferred.
- the polymer combination used according to the invention has self-thickening properties, the addition of further structural and / or thickening polymers is not absolutely necessary.
- the agents according to the invention preferably contain no further structuring agents and / or thickening polymers.
- the agents according to the invention are aerosol products, this necessarily contains a propellant.
- Propellants suitable according to the invention are, for example, N 2 O, dimethyl ether, CO 2 , air and alkanes having 3 to 5 carbon atoms, such as propane, n-butane, isobutane, n-pentane and isopentane, and mixtures thereof. Preference is given to dimethyl ether, propane, n-butane, isobutane and mixtures thereof.
- the alkanes mentioned, mixtures of said alkanes or mixtures of said alkanes with dimethyl ether are used as the sole blowing agent.
- the invention expressly also includes the concomitant use of propellants of the type of chlorofluorocarbons, but in particular of fluorocarbons.
- the sizes of the aerosol droplets or of the foam bubbles and the respective size distribution can be set for a given spraying device.
- blowing agent used varies depending on the specific composition of the composition, the packaging used and the desired product type, such as hair spray or hair foam.
- aerosol foam products contain the propellant preferably in amounts of 1 to 35 wt .-%, based on the total product. Amounts of 2 to 30 wt .-%, in particular from 3 to 15 wt .-% are particularly preferred. Aerosol sprays generally contain larger amounts of propellant.
- the blowing agent is used in this case in an amount of 30 to 98 wt .-%, based on the total product. Amounts of 40 to 95 wt .-%, in particular from 50 to 95 wt .-% are particularly preferred.
- the aerosol products can be prepared in the usual way.
- all constituents of the respective agent with the exception of the propellant, are introduced into a suitable pressure-resistant container. This is then closed with a valve.
- the desired amount of blowing agent is introduced.
- a second subject of the invention is therefore a process in which the cosmetic agent according to the invention is applied to the hair as a pump hair spray, aerosol hair spray, pump hair foam, aerosol hair foam or styling gel and is optionally incorporated into the hair with the palms and / or fingers.
- the desired deformation of the hair can be done with the fingers or hands and with suitable conventional aids such as comb or brush.
- a third object of the invention is the use of the means according to the invention for the temporary deformation of keratinous fibers.
- the compositions according to the invention and products which contain these agents are distinguished in particular by the fact that they give treated hair a very strong hairstyle hold, without rendering the hair brittle or inflexible. Rather, a pleasant, soft grip is achieved. Examples
- inventive styling agents A to F were prepared according to the following table.
- Copolymer of sodium acrylate, vinyl neodecanoate (about 29% by weight of solids in water, INCI name: ACRYLATES / VINYL NEODECANOATE CROSSPOLYMER)
- Vinyl pyrrolidone styrene copolymer (about 38-41% solids in water, INCI name: styrene / VP copolymer) (ISP) Active ingredient 60% in water; INCI name: CETEARYL ISONONANOATE, CETEARETH-20, CETEARYL ALCOHOL, GLYCERYL STEARATE, GLYCERIN, CETEARETH-12, CETYL PALMITATE (Cognis) Silicone Glycol Copolymer (INCI name: PEG-12 Dimethicone) (Dow Corning)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102008034104 | 2008-07-21 | ||
| DE102008035597A DE102008035597A1 (de) | 2008-07-21 | 2008-07-31 | Stylingmittel mit hohem Haltegrad und Pflegegefühl I |
| PCT/EP2009/058111 WO2010009956A1 (de) | 2008-07-21 | 2009-06-29 | Stylingmittel mit hohem haltegrad und pflegegefühl |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP2313077A1 true EP2313077A1 (de) | 2011-04-27 |
Family
ID=41171140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP09780005A Ceased EP2313077A1 (de) | 2008-07-21 | 2009-06-29 | Stylingmittel mit hohem haltegrad und pflegegefühl |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP2313077A1 (de) |
| DE (1) | DE102008035597A1 (de) |
| WO (1) | WO2010009956A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102015204146A1 (de) * | 2015-03-09 | 2016-09-15 | Henkel Ag & Co. Kgaa | "Mittel und Verfahren zur temporären Verformung keratinhaltiger Fasern" |
| DE102016225467A1 (de) | 2016-12-19 | 2018-06-21 | Henkel Ag & Co. Kgaa | Mittel und Verfahren zur temporären Verformung keratinhaltiger Fasern |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3753968A (en) | 1971-07-01 | 1973-08-21 | Westvaco Corp | Selective reaction of fatty acids and their separation |
| US5136093A (en) | 1991-02-06 | 1992-08-04 | Smith Ronald J | Quaternized panthenol compounds and their use |
| JP3020354B2 (ja) * | 1992-07-24 | 2000-03-15 | サンスター株式会社 | 毛髪用化粧料 |
| DE4413686C2 (de) | 1994-04-20 | 1996-10-24 | Henkel Kgaa | Kationische Zuckertenside, Verfahren zu ihrer Herstellung und deren Verwendung |
| DE19736906A1 (de) | 1997-08-25 | 1999-03-04 | Henkel Kgaa | Verfahren zur Herstellung von sulfatierten Fettsäurealkylenglykolestern |
| DE19738866A1 (de) | 1997-09-05 | 1999-03-11 | Henkel Kgaa | Schaumarme Tensidmischungen mit Hydroxymischethern |
| FR2814675B1 (fr) * | 2000-10-02 | 2002-12-20 | Oreal | Gel coiffant longue tenue |
| FR2816206B1 (fr) * | 2000-11-07 | 2005-06-17 | Oreal | Mousse coiffante longue tenue |
| DE10311120A1 (de) * | 2003-03-12 | 2004-09-23 | Basf Ag | Polymere Produkte und ihre Verwendung in kosmetischen Zubereitungen |
| EP1690878B1 (de) * | 2005-02-14 | 2007-09-12 | Rohm and Haas Company | Verdickungsmittel für wässrige Systeme |
-
2008
- 2008-07-31 DE DE102008035597A patent/DE102008035597A1/de not_active Withdrawn
-
2009
- 2009-06-29 WO PCT/EP2009/058111 patent/WO2010009956A1/de not_active Ceased
- 2009-06-29 EP EP09780005A patent/EP2313077A1/de not_active Ceased
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2010009956A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010009956A1 (de) | 2010-01-28 |
| DE102008035597A1 (de) | 2010-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2337553B1 (de) | Geschmeidiges stylingmittel mit hohem haltegrad | |
| WO2010020503A2 (de) | Mittel für keratinhaltige fasern, enthaltend mindestens ein spezielles amphiphiles kationisches polymer und mindestens ein spezielles amphiphiles, anionisches polymer | |
| EP2205210A2 (de) | Stylingmittel mit hohem haltegrad bei feuchtigkeit v | |
| EP2263645B1 (de) | Stylingmittel mit hohem Haltegrad bei Feuchtigkeit | |
| EP2272498B1 (de) | Stylingmittel mit hohem Haltegrad bei Feuchtigkeit | |
| EP2205209A2 (de) | Stylingmittel mit hohem haltegrad bei feuchtigkeit iv | |
| EP2313077A1 (de) | Stylingmittel mit hohem haltegrad und pflegegefühl | |
| EP2054024A1 (de) | Stylingmittel mit hohem haltegrad | |
| EP2489345B1 (de) | Stylingmittel mit hohem Haltegrad bei Feuchtigkeit III | |
| DE102006045965A1 (de) | Stylingmittel mit hohem Haltegrad | |
| WO2010009954A1 (de) | Stylingmittel mit hohem haltegrad und pflegegefühl | |
| DE102005057917A1 (de) | Wasserbeständige Frisiermittel | |
| EP2214624A2 (de) | Stylingmittel | |
| DE102009002538A1 (de) | Dauerwellmittel und Haarverformungsverfahren für moderne Frisuren | |
| DE102005013489A1 (de) | Haarreinigungsmittel mit optimiertem Fließverhalten | |
| EP1669109A1 (de) | Pflegende Haarbehandlungsmittel mit keratinreduzierenden Substanzen | |
| DE102009003291A1 (de) | Kosmetische Zusammensetzung und Verformungsverfahren für keratinische Fasern |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20110105 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR |
|
| AX | Request for extension of the european patent |
Extension state: AL BA RS |
|
| DAX | Request for extension of the european patent (deleted) | ||
| 17Q | First examination report despatched |
Effective date: 20120110 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R003 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
| 18R | Application refused |
Effective date: 20120430 |